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Abstract
Background: Atherosclerosis is the leading cause of cardiovascular disease (CVD). Traditional risk factors can be used to
identify individuals at high risk for developing CVD and are generally associated with the extent of atherosclerosis; however,
substantial numbers of individuals at low or intermediate risk still develop atherosclerosis.
Results: A case-control study was performed using microarray gene expression profiling of peripheral blood from 119
healthy women in the Multi-Ethnic Study of Atherosclerosis cohort aged 50 or above. All participants had low (,10%) to
intermediate (10% to 20%) predicted Framingham risk; cases (N=48) had coronary artery calcium (CAC) score .100 and
carotid intima-media thickness (IMT) .1.0 mm, whereas controls (N=71) had CAC,10 and IMT ,0.65 mm. We identified
two major expression profiles significantly associated with significant atherosclerosis (odds ratio 4.85; P,0.001); among
those with Framingham risk score ,10%, the odds ratio was 5.30 (P,0.001). Ontology analysis of the gene signature reveals
activation of a major innate immune pathway, toll-like receptors and IL-1R signaling, in individuals with significant
atherosclerosis.
Conclusion: Gene expression profiles of peripheral blood may be a useful tool to identify individuals with significant burden
of atherosclerosis, even among those with low predicted risk by clinical factors. Furthermore, our data suggest an intimate
connection between atherosclerosis and the innate immune system and inflammation via TLR signaling in lower risk
individuals.
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Introduction
Cardiovascular disease (CVD) is the leading cause of morbidity
and mortality in the United States and the developed world, and it
will soon be the leading cause in the developing world.
Atherosclerosis accounts for the vast majority of fatal and non-
fatal CVD events. Multivariable (MV) risk equations [1], such as
the Framingham risk score (FRS), that include traditional CVD
risk factors are generally correlated with presence and extent of
subclinical atherosclerosis; however, substantial numbers of
individuals with low (,10%) to intermediate (10% to 20%) FRS
still develop atherosclerosis [2,3], and the majority of CVD events
occur in those with ,20% 10-year predicted risk [4]. Refining risk
assessment by identifying those apparent outliers who have
significant atherosclerotic burden despite low or intermediate
predicted risk, and are therefore at higher risk for events than
average [5], could help identify novel mechanisms of atheroscle-
rosis development and progression and target preventive therapies
to those who are most likely to benefit.
Atherosclerosis is a disease of inflammation characterized by
interactions among platelets, leukocytes, and endothelial cells
[6,7,8]. Dysfunctional endothelium associated with the presence of
atheroma expresses surface molecules such as chemokines,
chemoattractants and adhesion molecules that are associated with
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circulating leukocytes and platelets. Therefore, peripheral blood
can be useful to measure the burden and further understand the
molecular mechanisms of atherosclerosis.
In the present study, we performed microarray gene expression
profiling of whole blood from a population of healthy women with
low to intermediate FRS to test whether gene expression profiles
could distinguish those with and without significant atherosclero-
sis. We further sought to identify genes and pathways associated
with significant burden of atherosclerosis among these women
predicted to be at lower risk for CVD events.
Results
Characteristics of participants
Among all 119 MESA women, 48 had significant subclinical
atherosclerosis (cases) and 71 had no evident subclinical athero-
sclerosis (controls); among those with FRS,10%, there were 39
cases and 69 controls. The characteristics of all 119 participants at
the fourth examination with and without evident subclinical
atherosclerosis are shown in Table 1. As expected, a greater
burden of CVD risk factors was observed among participants with
significant subclinical atherosclerosis. Age, smoking, systolic blood
pressure, and the use of cholesterol lowering medications were
significantly different between the two groups (p,0.05).
Overview of the gene expression profiles
The gene expression patterns differ greatly between cases and
controls. The sample dendrogram generated by hierarchical
clustering shows that the samples separate into two major
branches indicated by BL and BR (Figure 1). The largest cluster
of genes (G4) was responsible for separating the samples into these
two groups. The G4 cluster contains a large number of genes
encoding ribosomal proteins (RPS, RPL, MRPS, MRPL genes)
and genes related to oxidative phosphorylation (ATP5J, NDUFA1,
A6, A9, B8, S4, COX7C, 7A2, 17), suggesting a role for
mitochondrial function and energy metabolism. More African
Americans and fewer whites were found in the BR branch than in
the BL branch (BR: 38% vs BL: 15% for African American, BR:
40% vs BL: 68% for whites, P=0.002). More cases were found in
the BL branch, however, the association of these two branches
with atherosclerosis status did not reach statistical significance (BL
vs BR branch: 46% vs 33%, P=0.19). Each of these two branches
further clustered into two sub-branches (BL1, BL2, BR1, and
BR2). Two major gene clusters (G1 and G3) distinguish between
BL1 and BL2. The majority of genes in G1 are related to immune
and inflammatory response (TLR1,2,4,5,6,8, IL1b, IL1R2,
IL1RN, NAMPT, FCGR2A, PTGS2) while cell cycle and
apoptosis-related genes are found in G3 (BCL2, BAG3, BLK,
ATM, MYC, CD27, TNFRSF25). An inverse correlation of gene
expression between these two gene clusters is evident. In contrast,
the distinct feature between BR1 and BR2 was indicated by gene
cluster G2. Several genes involved in lipid and reactive oxygen
species metabolic process were discovered (PRDX2, GPX1,
GPX4, GLRX5, HAGA, ADIPOR1, OSBP2, CHPT1,
PNPLA2). An examination of the prevalence of atherosclerosis
among these four sub-branches shows the highest rate in BL2 (22/
43, 51%) and lowest rate in BR2 (5/20, 25%), while both the other
two branches, BR1 and BL1, had the same rate of 37.5% (9/24
and 12/32). Of note, two subsets indicated by purple bars within
the BL2 had the highest rate (both 9/13, 69%) of atherosclerosis.
Both subsets are characterized by higher expression of G1 and
lower expression of G3, while the subset on the right also had
lower expression of G2.
Association of gene expression profiles with
atherosclerosis
The distribution of the 2,057 P-values (Figure S1) using t tests
comparing all 48 cases and 71 controls showed a higher frequency
of probes at low P values than would be expected by chance alone
(229 probes, or 11%, with P,0.05). One hundred and eighty
genes were found to have an FDR,24% (215 genes with
Table 1. Characteristics of 119 MESA non-diabetic women with low or intermediate Framingham risk scores.
Variable
With
Atherosclerosis
(n=48)
Without Atherosclerosis
(n=71) P Value
*
Framingham Risk Score (%) 5.864.5 2.662.9 ,0.001
Age, years 69.466.8 64.367.3 ,0.001
Race
{ (%) 54/27/13/6 58/24/14/4 0.93
Body-Mass Index (Kg/m
2) 28.266.0 27.265.8 0.38
Systolic BP (mm Hg) 130.6621.0 116.3618.4 ,0.001
Diastolic BP (mm Hg) 68.769.0 66.9610.5 0.30
Total cholesterol (mg/dL) 200.2634.3 193.4631.5 0.28
LDL cholesterol (mg/dL) 117.6635.5 108.3628.5 0.14
HDL cholesterol (mg/dL) 60.0613.1 72.9616.0 0.28
Triglycerides (mg/dL) 113.1669.8 112.1673.4 0.72
hs-CRP
{ (mg/L) 5.669.4 2.363.2 0.02
Current smoker (%) 50.0 26.7 0.02
Lipid-lowering medication use (%) 47.9 14.1 ,0.001
Anti-hypertension medication use (%) 47.9 32.4 0.13
*p-value by t-test or chi-square test as appropriate.
{non-Hispanic white /African American/Hispanic/Chinese.
{hs-CRP levels were measured at MESA baseline examination during 2000,2002.
doi:10.1371/journal.pone.0021067.t001
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differentially expressed. This result suggests that a gene signature
associated with atherosclerosis may exist; however, the moderate
FDR of differentially expressed genes implicates that heteroge-
neous expression profiles may be present within the case and/or
control groups.
The multiple random validation procedure using top 50–60
genes with smallest p-values identified two major gene expression
profiling (or molecular) subtypes with an odds ratio of 4.85
(sensitivity 60%, specificity 76%) for the association with
atherosclerosis (see Figure S2 and S3). We termed these molecular
profiles as Associated with Atherosclerosis (AWA) or not AWA.
The odds ratio remained high at 5.3 (sensitivity 62%, specificity
77%) when only the 108 women with FRS ,10% were
considered. As expected, there was a significantly greater number
of differentially expressed genes (1,254, 61%) between these two
molecular profiles. As shown in Table 2, age and systolic blood
pressure were two risk factors significantly different between those
with the two molecular profiles, but less of a difference compared
with Table 1. Using multiple logistic regression with adjustment
for FRS, the gene expression profiling subtypes remained
significantly associated with atherosclerosis with an odds ratio of
3.8 (95% CI = [1.6, 8.9], P=0.002) for all 119 participants and
3.7 (95% CI = [1.5, 9.3], P=0.004) for the 108 low-FRS
participants.
A sensitivity analysis was further performed by excluding those
on lipid lowering medication, leaving 25 cases and 61 controls for
comparison. The multiple random validation procedure on this
subset of samples resulted in an association similar to the results
from the entire 119 samples (data not shown). Similarly, the
association did not change substantially by excluding smokers or
those taking medications for hypertension.
Ontology analysis of differentially expressed genes
In order to better characterize pathways associated with the
AWAprofile, we performed ontologyanalysis on the top 344probes
representing 325 unique genes that had an FDR ,0.1% from the
comparison between the two molecular profiles. Information on
these 325 genes is provided in Table S1. The genes that were
identified as associated with the AWA profile strongly represented
by members of the innate immune signaling pathway. Genes
representing several canonical pathways including Toll-like recep-
tors (TLRs), NF-kB, p38 MAPK, and IL-10 signaling were
identified (Table 3). All of these pathways have extensive cross talk
in inflammatory signaling. The key genes involved in these
pathways include six TLRs (TLR1,2,4,5,6,8), IL1b, IL1RN,
IL1R2, IRAK3, and MAPK14. A representation of this immune
and inflammatory network from a subset of the 325 differentially
expressed genes is shown in Figure 2, in which several genes are also
involved in apoptosis and mobilization of calcium. This highly
Figure 1. Gene expression patterns among individuals with and without atherosclerosis. 2,057 probes were selected for which expression
coefficient of variation was .0.3 and for which at least a half of the 119 microarray samples were detected for the expression values. The
unsupervised hierarchical clustering dendrogram shows the relationship among the samples and corresponding gene clusters. Samples have been
color-coded by their phenotype (atherosclerosis in red, non-atherosclerosis in black), race (white in blue, Chinese in yellow, Hispanic in red, and
African American in black), and age. Age and each probe have been centered on their mean expression values across all samples analyzed.
Measurements that are above the mean are colored red and those below the mean are colored green. Groups of genes on the right hand side
indicated with colored bars are shown in greater detail and labeled G1–G4. The sample dendrogram shows 4 branches (BL1, BL2, BR1, and BR2). Two
subsets (purple bar) under the branch BL2 are enriched with atherosclerosis (both 9/13).
doi:10.1371/journal.pone.0021067.g001
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immunesystem,includingtheTLRandIL-1signalingpathways(on
the right side) and downstream signaling pathways (PTGS2,
MAPK14, DUSP1 and DUSP6). Also upregulated are genes that
promote myeloid cell growth and survival (CSF2RA, CSF2RB,
CSF3R, C5aR1, GBP1, in addition to the TLR and IL-1 signaling
molecules). These data suggest that the AWA profile was an
Activated Innate Immune Gene (AIIG) signature. The network also
shows decreased expression in genes related to adaptive immunity,
including the genes important in T cell activation and maturation
(CD3, CD3 epsilon, CD27, CD6, and ZAP70) and CCR7 which is
important in the recruitment of T cells and myeloid dendritic cells.
Consistent with the resultfromIPA,DAVIDbioinformaticsanalysis
also showed enrichment in response to wounding, immune/
inflammatory response, leukocyte activation, and TLR signaling.
Other than immune response and cytokine and chemokine
mediated signaling pathways, PANTHER analysis also revealed 8
genes involved in the apoptosis pathway. Information regarding the
enriched functional categories and genes from these bioinformatics
analyses are provided in Table S2.
Comparison with gene expression pattern of peripheral
blood leukocytes after endotoxin injection
To furthervalidate the observation that TLR pathway is activated
in AWA profile, we compared our gene expression data with
Calvano’s study[9], which examined the gene expression profiles in
blood leukocytes of human subjects who received bacteria endotoxin
injection – an established model of acute inflammatory response via
TLR activation. For Calvano’s study, fold changes and P values for
genes were calculated by comparing expression levels at two or six
hours after endotoxin injection with baseline levels. A total of 501
and 583 probes, respectively, were found to have P values ,0.05 in
both our data and Calvano’s data at two and six hours after
endotoxin injection (P,10
25 and P,10
215). More importantly, a
significant concordance of fold changes was observed between both
studies (Figure 3), with a stronger correlation of fold change between
the two studies at six hours after endotoxin injection than at two
hours (Pearson correlation 0.59 vs 0.47, P,10
215).
Confirmation of gene expression data
Quantitative real-time RT-PCR was performed to confirm the
RNA expression levels of eight selected genes involved in various
functions including lipid metabolism, immune and inflammatory
response, apoptosis, cell proliferation, and hypoxia signaling
(TNFSF14, TLR8, TLR4, CREB5, IL1b, IL1RN, EGLN1,
TGFA). All eight genes showed high correlation (0.47,0.65,
P=5.6N10
28,1.8N10
215, see Table S3) between the microarray
expression and RT-PCR measures.
The association of AIIG signature with atherosclerosis
among men
We further characterized the association of atherosclerosis with
the AIIG signature described above, employing peripheral blood
from 16 white men aged 65–80. The clinical characteristics of
these 16 men are shown in Table S4. Most of CVD risk factors are
comparable between the two CAC groups. However, lipid-
lowering medication use is significantly higher among those with
high CAC (75% vs 25%, P=0.05) while their total cholesterol
levels were lower (154 mg/dL vs 193 mg/dL, P,0.001). Cluster
analysis was performed using the top 50 genes with smallest P-
values from the AIIG signature. As shown in Figure 4, two major
branches were identified that were significantly associated with
CAC status (p=0.009, x
2 test). The left branch consisted of all
eight men with high CAC and two men with low CAC, while the
right branch consisted of six men, and all had CAC,1. Of note,
the two men with low CAC on the left branch had the highest
CAC scores (1.2 and 0.9) among the eight men with low-CACs.
Because CAC score is highly correlated with the sums of
histological artery plaque areas[10], this result suggests that the
AIIG signature-atherosclerosis association exists in both genders.
Table 2. Characteristics of 119 MESA non-diabetic women between two major molecular profiles (e.g., Associate with
Atherosclerosis (AWA) or not AWA).
Variable
With AWA profile
(n=46)
Without AWA profile
(n=73) P Value
*
Framingham Risk Score (%) 5.064.0 3.163.8 0.01
Age, years 68.866.5 64.867.7 0.003
Race
{ (%) 59/20/17/4 55/29/11/5 0.58
Body-Mass Index (Kg/m
2) 27.365.8 27.865.9 0.62
Systolic BP (mm Hg) 128.2621.2 118.1619.4 0.01
Diastolic BP (mm Hg) 69.0610.3 66.669.6 0.21
Total cholesterol (mg/dL) 196.4632.4 195.9633.1 0.94
LDL cholesterol (mg/dL) 111.8633.4 112.2630.9 0.95
HDL cholesterol (mg/dL) 63.4614.1 60.6615.4 0.31
Triglycerides (mg/dL) 105.4662.6 116.9677.0 0.38
hs-CRP
{ (mg/L) 5.3610.1 2.762.4 0.08
Current smoker (%) 45.6 30.1 0.13
Lipid-lowering medication use (%) 36.9 21.9 0.12
Anti-hypertension medication use (%) 47.8 31.5 0.11
*p-value by t-test or chi-square test as appropriate.
{non-Hispanic white /African American/Hispanic/Chinese.
{hs-CRP levels were measured at MESA baseline examination during 2000,2002.
doi:10.1371/journal.pone.0021067.t002
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Atherosclerosis is the main cause of clinical CVD events.
Inflammation plays a central role at all stages of this disease [6].
However, the agents and associated signaling pathways responsible
for initiating and perpetuating atherogenesis remain to be
elucidated. The present study used global gene expression profiles
of peripheral blood which identified abundant genes that are
involved in innate immunity and host defense (AIIG signature)
which were strongly associated with significant atherosclerosis
among women with low to intermediate FRS. A similar
association was also observed among men with advanced
atherosclerosis who did not have history of CVD. The finding
that increased expression of genes from a number of signaling
pathways was associated with atherosclerosis suggests a systemic
immune activation mediated through the TLR and IL-1 receptor
(IL-1R) signaling pathways, and by the pro-inflammatory
mediators MAP kinases (MAPK14 and FOS) and STAT3. This
observation is further supported by the striking consistency of
expression patterns between our and Calvano’s study, suggesting
that a chronic low grade inflammation through activation of
TLR/IL-1R signaling may be important in the pathogenesis of
atherosclerosis, prior to the appearance of any symptoms. Thus,
low grade activation of the TLR/IL-1R signaling pathway may
represent a potential biomarker for use in measuring presence
and/or burden of atherosclerosis.
Prior studies have demonstrated the increased expression of
TLR2 and TLR4 on monocytes from patients with angina and
acute coronary syndrome [11,12]. Further, patients with recurrent
Figure 2. Network representation of the atherosclerosis-associated immune and inflammatory response of peripheral blood. The
network consists of 55 genes showing perturbed expression (green, decreased; red, increased expression). This highly connected network is
characterized by activation of toll-like receptor and IL-1 signaling (on the right side).
doi:10.1371/journal.pone.0021067.g002
Table 3. Atherosclerosis-associated genes and the
corresponding enriched canonical pathways identified by
Ingenuity Pathway Analysis.
Signaling
Pathways Molecule
Toll-like
Receptor
TLR1, TLR2, TLR4, TLR5, TLR6, TLR8, FOS, IRAK3, MAPK14
P38 MAPK MAPK4K1, MAPK14, IL1b, IL1RN, IL1R2, IRAK3, DUSP1, CREB5
IL-10 FCGR2A, FOS, IL1b, IL1RN, IL1R2, MAPK14, STAT3
NF-kB IL1b, IL1RN, IL1R2, IRAK3, TGFA, ZAP70, TLR1, TLR2, TLR4,
TLR5,
TLR6, TLR8
doi:10.1371/journal.pone.0021067.t003
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ligand lipopolysaccharide [13]. In contrast, our data suggests that
the increased expression of TLR2 and TLR4, and other members
of the TLR family, is observed in peripheral blood prior to the
onset of clinical symptoms. Supporting the role of TLR2 and
TLR4, response for peripheral blood monocytes to TLR2 and
TLR4 ligands was significantly associated with the degree of
coronary artery stenosis [14]. Additionally, in human atheroma,
TLRs 1, 2, 4, 5 and 6 are highly up-regulated when compared to
tissue from healthy arteries [15]. Further supporting the role of
TLR2, employing cells isolated from carotid endarterectomies of
patients with atherosclerosis, inhibition of TLR2 and MyD88,
which mediates signals for all TLRs except TLR3, suppressed the
expression of spontaneously expressed inflammatory mediators
and matrix metalloproteinases [16].
Experimental studies have consistently demonstrated the
significant role of innate immunity in atherogenesis. Genetic
deletion of TLR4 or TLR2 resulted in significant reduction of
arterial plaques in atherosclerosis-prone apoE or LDLR deficient
mice [17,18,19]. Additionally, both IL1b and IL1a contribute to
the pathogenesis of experimental atherosclerosis [20,21]. Toll-like
receptors have also been implicated in several autoimmune and
infectious diseases [22,23]. Epidemiological studies have demon-
strated that individuals with systemic lupus erythematosus,
rheumatoid arthritis, chronic infectious diseases or high levels of
circulating bacterial endotoxin have a substantially increased risk
of atherosclerosis [24,25,26,27]. These associations may be
mediated by signaling through TLR2 (which serves as a co-
receptor with TLR1 or TLR6), 4, 7, 8 and 9 [28]. Each of these
TLRs except TLR 7 and 9 was increased in our population with
atherosclerosis.
T cell activation has been implicated in the pathogenesis of
atherosclerosis. T cells are enriched in atherosclerotic lesions [29].
Further, T cell activation has been implicated in patients with
acute coronary syndromes [30,31,32]. In contrast, the individuals
with atherosclerosis in our study demonstrated a reduction in the
expression of genes which contribute to T cell activation and
maturation (CD3, CD3E, CD6, CD27). This apparent discrep-
ancy may be explained by the fact that increased T cell activation
has been described in patients with acute coronary syndrome.
Figure 3. Expression changes of 2,057 probes between acute and chronic inflammation. X-axis: fold changes of gene expression
comparing AWA profile with not AWA profile. Y-axis: fold changes of gene expression comparing expression levels before and after endotoxin (LPS)
injection. A stronger correlation of fold changes between chronic inflammation and acute inflammation six hours after endotoxin injection was
observed. Red dots: 325 genes in the activated innate immune gene signature. AWA: associated with atherosclerosis.
doi:10.1371/journal.pone.0021067.g003
Figure 4. Association of expression pattern with coronary artery calcium (CAC) among men. Cluster analysis of 16 selected men from the
CHAS cohort was performed using top 50 genes from the activated innate immune gene (AIIG) signature.
doi:10.1371/journal.pone.0021067.g004
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reminiscent of rheumatoid arthritis, which is driven mediated in
large part through activation of the innate immune system [33].
Patients with rheumatoid arthritis demonstrate activated macro-
phages and T lymphocytes in the synovial tissue. However, these
patients demonstrate decreased T cell mediated adoptive immu-
nity in the circulation which improves following therapy [33,34].
These observations suggest that activation of the innate immune
system may result in reduction of adaptive immunity as measured
peripherally.
Recently, two microarray gene expression studies [35,36] of
peripheral blood leukocytes in patients with angiographically-
documented coronary stenosis were reported by Wingrove et al.
and Sinnaeve et al.. We applied our innate immune gene signature
to their expression data, but failed to verify the associations
observed in either study. We found our 325 atherosclerosis-
associated genes overlapped little (2 genes) with Sinnaeve’s 160
genes associated with presence of coronary stenosis .50%. We
observed somewhat greater overlap (14 genes) between our gene
signature and Wingrove’s 106 differentially-expressed gene that
were identified from their literature search or their microarray
results in patients referred for angiography and with $75%
stenosis in one major coronary artery or $50% in two major
arteries. Most of these overlapping genes belong to the TNF
superfamily, IL1R signaling, and receptors for IL8 or colony
stimulating factor. There are several potential reasons for the lack
of substantial overlap between our results and those of Sinnaeve
and Wingrove. These could include use of different measures to
define the presence of atherosclerosis, since CAC presence and
increased IMT may represent different (earlier) phases of
atherosclerosis progression than presence of severe coronary
stenosis. Likewise, there were clear differences in methods for
selection of participants between studies. Our study participants
were at lower risk for CVD events and are all asymptomatic, while
cases in the Sinnaeve and Wingrove studies were referred for
angiography on clinical grounds and some had recent acute
coronary syndromes; furthermore, control participants in these
two studies may have had atherosclerosis, just not severe enough to
meet the case definition, whereas our control participants appear
to be substantially free of atherosclerosis. Finally, there were
differences in statistical analyses used to define differentially
expressed genes. Sinnaeve et al used correlation analysis as
opposed to two-group comparisons used in our and the Wingrove
studies. All of these factors may have contributed to the minimal
gene overlap observed between these 3 studies.
The findings from the present study have several potential
clinical implications. Higher burden of atherosclerosis, as mea-
sured by CAC or carotid IMT, is associated with significantly
greater risk for CVD events in the short term, independent of
traditional risk factors [37,38,39,40]. Our data suggest that several
genes, especially those in the TLR/IL-1R signaling pathway, may
serve as potential markers of significant atherosclerosis burden
even for those predicted to be at lower risk by traditional risk
equations. Toll-like receptors have been suggested as therapeutic
target for several inflammatory diseases, including atherosclerosis
[41]. Perhaps this signal or similar data indicating TLR/innate
immune activation could be used to identify individuals who
would benefit from more intensive prevention efforts. An
approach that combines gene expression changes in TLR signaling
and conventional CVD risk factors may enhance risk prediction
for atherosclerosis. Such a strategy would require validation in
larger samples.
Some limitations of the current study should be acknowledged.
First, because of the cross-sectional nature of our study, the causal
relationship of TLR signaling with atherosclerosis cannot be
established in the present data. Second, our study only included
119 women aged 50,86 and 16 men aged 65,80. It is unknown
whether our gene signature is applicable to identify atherosclerosis
among younger adults. Larger and perspective studies are
warranted to examine expression alterations of members of TLR
and IL-1R signaling pathways in association with developing
subclinical atherosclerosis. Nonetheless, our translational finding is
unique in revealing an AIIG signature that was associated with
significant atherosclerotic burden, even among a group predicted
to be at low risk for atherosclerosis and clinical CVD.
Conclusions
We used global gene expression profiles of whole blood to
systematically examine the dynamic transcriptional alterations
associated with atherosclerosis among women with low to
intermediate predicted risk for the disease. Our results suggest
the involvement of the innate immune system in atherogenesis and
that whole blood provides an accessible and informative source of
transcriptomal information regarding the inflammatory status of
atherosclerosis in the preclinical phase of the diseases. Because of
the easy access of blood samples, expression profiles of whole
blood may be a useful tool to assess the burden of atherosclerosis
and could potentially be used to enhance the risk prediction of
CVD beyond the traditional risk factors. Future studies will be
needed to validate our findings.
Methods
Ethics statement
The Institutional Review Boards at all Multi-Ethnic Study of
Atherosclerosis (MESA) sites (Northwestern University, Wake
Forest University, Johns Hopkins University, Columbia Universi-
ty, University of Minnesota, and UCLA) as well as the Chicago
Health Aging Study (CHAS) center (Northwestern University)
approved the study, and all participants gave written informed
consent.
Participants’ blood samples
A subset of 119 study participants was selected from the MESA
cohort. MESA is designed to study the prevalence, risk factors, and
progression of subclinical cardiovascular disease in a multiethnic
cohort. A detailed description of the study design and methods has
been published previously [42]. Briefly, 6814 participants aged 45
to 84 years and free of known clinical CVD were recruited from 6
US communities – Baltimore, MD, Chicago, IL, Forsyth County,
NC, Los Angeles, CA, New York, NY, and St. Paul, MN. The
baseline examination was performed between July 2000 and
September 2002. Participants included white (38%), black (28%),
Hispanic (22%), and Chinese (12%) Americans. MESA conducted
three subsequent examinations of the cohort between 2002 and
2007.
In our case-control study, cases were selected as having a
coronary artery calcium (CAC) score $100 and common carotid
intima-media thickness (CC-IMT) $1.0 mm. Controls were
selected as having a CAC score #10 and CC-IMT #0.65 mm.
Additionally, both cases and controls were selected from those
without diabetes or history of CVD who had an FRS less than
10% at baseline examination (2000,2002). Among all MESA
women, only 48 women agreed to participate and met the
selection criteria as cases with significant atherosclerosis burden
despite low predicted risk for CHD. We also selected potential
control participants from among MESA women based on similar
age and race –71 women were identified as controls and agreed to
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these 119 participants, the FRS of 11 participants had increased
from 11% to 20% when the MESA data for the fourth
examination (2005,2007; concurrent with the present study)
became available. Carotid IMT was measured for all MESA
participants only at the baseline examination. Measurement of
CAC was performed for all MESA participants at the baseline
examination. Follow-up testing for CAC was performed in two
stages: 50% of participants returned from September 2002 to
January 2004 (examination 2), and the remainder returned from
March 2004 to July 2005 (examination 3). Therefore, we used the
CAC score from examination 2 or 3 for these 119 participants. All
these 119 participants were called back during April-July 2007 to
have 5 ml whole blood drawn into two PAXgene tubes for RNA
isolation.
PAXgene blood samples of additional 16 white men without
diabetes or history of CVD from the CHAS cohort were selected
for gene expression profiling. The blood samples of these men
were collected during their clinical visits between April 2009 and
July 2009. Because IMT data were not available in CHAS, cases
and controls were identified based on their CAC scores. Eight of
these 16 men had CAC scores 446,1,206. The other eight had
CAC scores ,2. The Institutional Review Boards at each MESA
site as well as the CHAS center (Chicago, IL) approved the study,
and all participants gave informed consent.
CAC and IMT Assessment
Scanning centers assessed CAC by chest-computed tomography
using either a cardiac-gated electron-beam computed tomography
scanner at three MESA field centers or a multi-detector computed
tomography system at the other three MESA field centers. Each
participant was scanned twice, and these scans were read
independently at a central reading center. The amount of calcium
was quantified with the Agatston scoring method. The average
Agatston score was used for data analysis. Carotid IMT was
measured using high-resolution B-mode ultrasonography of the
right and left near and far walls of the internal carotid and common
carotid arteries. Images were acquired bilaterally for both the
common and internal carotid arteries. The CHAS used a similar
method to assess CAC. The methodology for acquisition and
interpretation of the scans has been documented previously [43,44].
RNA extraction and microarray experiment
Five ml whole blood from each participant was drawn into two
PAXgene tubes and incubated at room temperature for three
hours before being frozen at 270uC. RNAs were extracted using
the PAXgene blood RNA extraction kit according to the
manufacture’s protocol. The concentration of the extracted total
RNA and their quality were measured by NanoDrop (Thermo-
fisher) and Bioanalzyer 2100 (Agilent), respectively. Total RNA
preparations with 260/280 ratio between 1.98–2.22 and RIN
number .7.4 with enough quantity were used for the expression
analysis. Globin reduction was performed using the Ambion
GLOBIN clear kit. The quality of the globin-reduced RNA
samples was assessed by Agilent 2100 Bioanalyzer. High quality
samples were used to make first and second strand DNA followed
by an IVT reaction. The size distribution of the resulting biotin
labeled cRNA and the yield was checked by Agilent 2100
Bioanalyzer and NanoDrop, respectively. A normalized amount of
labeled cRNA was hybridized) for 18 hours at 55uC to the Sentrix
Human Ref-8 v2 Expression BeadChip for the 119 MESA
samples and HumanHT-12 V4 Expression BeadChip for the 16
CHAS samples (Illumina, Inc, San Diego). After washing and
staining with Cy3, the chips were scanned on the Illumina iScan.
The Illumina Human Ref-8 v2 BeadChip allows genome-wide
expression profiling of more than 22,000 transcripts of genes and
known alternative splice variants from the RefSeq database while
the HumanHT-12 V4 Expression BeadChip targets more than
47,000 transcripts of genes, gene candidates, and splice variants.
The microarray analysis was performed at the Northwestern
Genomic Core Facility at the Center for Genetic Medicine. All the
119 MESA RNA samples were run on 5 different days within a
week. Samples collected from six MESA field centers were
randomly assigned to different chips and days. All case and control
samples in each MESA field center were also randomly assigned to
different chips and days. The 16 CHAS RNA samples were also
randomly assigned to two different chips and run on the same day.
Quantitative RT-PCR
RNA levels of eight selected genes were analyzed by
quantitative real time RT-PCR using the TaqMan chemistry on
the 7300 Real-Time PCR System from Life Technologies.
GAPDH was used as the endogenous control. Relative expression
levels of these genes were determined by the delta-delta threshold
cycle (DDCT) method.
Data analysis
BeadStudiosoftwarewasusedtotranslatethe scannedimagesinto
expression data, which were further log transformed and normalized
by the quantile normalization procedure using the Bioconductor
package: affy. Gene expression data from microarray experiments
are known to have substantial background noise to signal ratios for
genes expressed at the lower levels. To reduce the chance of
identifying such genes, genes with a coefficient of variation less than
0.03 across all 119 MESA samples or a P value for expression
detection call less than 0.01 for 60 samples or fewer were excluded,
resulting in 2,057 probes for data analysis. Average linkage
hierarchical clustering was performed for these 2,057 probes in the
119 MESA samples using Cluster 3.0 software (http://rana.lbl.gov/
EisenSoftware.htm) using Pearson correlation as a distance metric.
Significance analysis of microarray (SAM) [45] and the method
developed by Storey and Tibshirani [46] were used to estimate the
false discovery rate (FDR) and the number of differentially expressed
genes forcomparisons between caseand controlgroupsandbetween
the two major gene expression profiling subtypes. Three widely-used
applications (Ingenuity Pathway Analysis (IPA), PANTHER ontol-
ogy analysis [47], and DAVID bioinformatics software [48]) were
applied to identify pathways or biological functions of differentially
expressed genes associated with atherosclerosis. The full MIAME-
compliant microarray data were submitted to the NCBI Gene
Expression Omnibus data repository (http://www.ncbi.nlm.nih.
gov/geo/) under accession number GSE20129.
Identification of major gene expression profiling
subtypes
We used a multiple random validation procedure [49] to
identify major gene expression profiling subtypes associated with
atherosclerosis among the 119 MESA participants. Specifically,
the MESA data set was first randomly divided into ten groups of
approximately equal size. Each group included approximately the
same number of samples from participants with significant
subclinical atherosclerosis. For each group (test set), a classifier
was built with the remaining nine of ten groups (training set) and
then used to categorize samples in the group as atherosclerosis or
non-atherosclerosis. The classification was performed across all ten
groups. For each randomly drawn training set of samples, a multi-
gene support vector machine classifier was constructed. For each
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controls within a training set was calculated. Genes (1–100 genes)
with the largest absolute values of t statistics were selected to
construct a support vector machine model using an R software
package, e1071. This model was then applied to classify samples
within the complementary test set as atherosclerosis or non-
atherosclerosis. This whole procedure was repeated 1,000 times,
and the final classification status was determined by the majority
vote of the 1,000 classification results (e.g. .500 votes). The
samples were separated into two major gene expression profiling
subtypes based on their final classification status.
Gene selection for comparison between the present
study and Calvano’s study
We used the Northwestern Unigene system to map our 2,057
Illumina probes to those in the Affymetrix U133 +2 chip used in
Calvano’s study. 1,841 unique genes were found in both
microarray chips.
Supporting Information
Figure S1 Distribution of 2,057 P-values from t tests comparing all
71 controls and 48 cases among the MESA women. The dashed
black line is the uniform distribution under the null hypothesis of no
differential expression. If there were no differential expression
observed, all the bars will be approximately at the height of the
dashed black line. For these data, the observed P-value distribution is
skewedtotheright.The dashedredlineindicatesthataproportionof
non-differentially expressed genes (80.4%).
(TIF)
Figure S2 Association of atherosclerosis with gene expression
profiles of peripheral blood. The optimal association from the
multiple random validation procedure was achieved using a set of
50–60 genes, resulting in an odds ratio of 4.85. When only the 108
women with FRS,10% were considered, the odds ratio was 5.3.
SVM: support vector machine. FRS: Framingham risk score.
(TIF)
Figure S3 Multiple random validation using 50–60 genes
identified 2 major gene expression molecular subtypes: 29 true
positives (cases) + 17 false positives (controls); 54 true negatives
(controls) + 19 false negatives (cases). Distribution of 2,057 P-
values from t tests for comparisons between (a) true positives (TP,
n=29) vs false negatives (FN, n=19) ; (b) true negatives (TN,
n=54) vs false positives (FP, n=17); (c) TP vs FP; (d) TN vs FN. A
large proportion of genes (45%) were estimated to be differentially
expressed between the TPs and the FNs. Similar result was
observed between the TNs and the FPs. On the other hand, no
differentially expressed genes can be identified between the TPs
and the FPs or between the TNs and the FNs.
(TIF)
Table S1 344 atherosclerosis-associated probes.
(DOC)
Table S2 Selected enriched pathways and functional categories.
(DOC)
Table S3 Correlation of gene expression between microarray
and RT-PCR experiments.
(DOC)
Table S4 Characteristics of 16 CHAS non-diabetic white men
with low or high coronary artery calcium (CAC) score.
(DOC)
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